The purpose of this set of studies is to evaluate client- and system-level outcomes achieved as a result of services provided by Ryan White CARE Act (RWCA) grantees and providers. Priorities for evaluating the impact of the RWCA are responsive to grantee requests for assistance with evaluation, the Government Performance and Results Act (GPRA), and amendment to the CARE Act of 1996. Questions to be addressed include whether HRSA's HIV/AIDS programs are: 1) enrolling underserved and vulnerable populations in primary health care; 2) providing clients with quality/continuity of primary care similar to care received by other people living with HIV; 3) providing services that remove barriers to primary care services for CARE Act clients; 4) reducing morbidity and perinatal transmission of HIV disease; 5) reducing HIV-related mortality; and 6) adapting to change in health care (e.g., availability of anti-retroviral therapies and the growth of managed care). The California State Office of AIDS is investigating whether RWCA programs reduce opportunistic infections, and whether there are increased or slowed rates of decline in CD4 counts and declines in perinatal transmission of HIV disease. The New York University Medical Center is examining outcomes over three time periods: pre-RWCA funding (1985-1991), RWCA implementation (1992-1996), and RWCA maturity (1997-2000). The University of Pittsburgh is analyzing Pittsburgh AIDS Center for Treatment outcomes data during 1997-1998. The Washington University School of Medicine is studying patients enrolled during 1997-1998 in the Men's HIV Program and the Helena Hatch Special Care Center for adolescent and adult women with HIV.
AGENCY SPONSOR: HIV/AIDS Bureau
FEDERAL CONTACT: Faye Malitz, 301-443-3259
PIC ID: 6177
PERFORMER: California State Office of AIDS, Sacramento, CA